secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001558370-23-014996
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma approves $118K CEO bonus and $83K CFO bonus for 2023
-------------------------------------------------------------------

- CEO Joshua R. Disbrow awarded $118,000 bonus (33% of target).
- CFO Mark K. Oki awarded $83,000 bonus (50% of target).
- Bonuses to be paid in January 2024; full payment if employment terminates early.
- Approved by Compensation Committee on August 11, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023014996/0001558370-23-014996-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023014996/aytu-20230811x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-014996

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer